PTC Therapeutics
PTCT
#3138
Rank
โ‚น436.80 B
Marketcap
โ‚น5,228
Share price
-3.27%
Change (1 day)
-22.02%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2026 (TTM): -โ‚น7.4 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are โ‚น1.15 Billion. In 2025 the company made an earning of โ‚น64.55 Billion, an increase over its 2024 earnings that were of -โ‚น33.66 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น7.4 Billion-111.46%
2025 โ‚น64.55 B-291.84%
2024 -โ‚น33.66 Billion-47.84%
2023 -โ‚น64.51 Billion18.49%
2022 -โ‚น54.45 Billion13.34%
2021 -โ‚น48.04 Billion28.64%
2020 -โ‚น37.34 Billion67.94%
2019 -โ‚น22.24 Billion87.28%
2018 -โ‚น11.88 Billion64.95%
2017 -โ‚น7.2 Billion-45.13%
2016 -โ‚น13.12 Billion-16.72%
2015 -โ‚น15.76 Billion72.64%
2014 -โ‚น9.13 Billion90.89%
2013 -โ‚น4.78 Billion96.58%
2012 -โ‚น2.44 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.171 T-14,958.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚น422.68 B-5,460.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น10.71 Billion 35.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น12.14 Billion 53.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-โ‚น12.38 Billion 57.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น63.45 Billion 704.62%๐Ÿ‡บ๐Ÿ‡ธ USA